Vamana, Inc in Texarkana, Arkansas - Dialysis Center

Vamana, Inc is a medicare approved dialysis facility center in Texarkana, Arkansas and it has 11 dialysis stations. It is located in Miller county at 422 Beech St, Texarkana, AR, 71854. You can reach out to the office of Vamana, Inc at (870) 773-1111. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Vamana, Inc has the following ownership type - Profit. It was first certified by medicare in December, 2007. The medicare id for this facility is 042581 and it accepts patients under medicare ESRD program.

Name	Vamana, Inc
Location	422 Beech St, Texarkana, Arkansas
No. of Dialysis Stations	11
Medicare ID	042581
Managed By	Independent
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Vamana, Inc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

Dialysis patients with Hemoglobin data

10

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	33
  Adult patient months included in Kt/V greater than or equal to 1.2	282
  Percentage of adult patients getting regular hemodialysis at the center	84
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Vamana, Inc with elevated calcium levels.

Patients with hypercalcemia	34
Hypercalcemia patient months	296
Patients with Serumphosphor	38
Patients with Serumphosphor less than 3.5 mg/dL	16
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	24
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	20
Patients with Serumphosphor from 5.6 to 7 mg/dL	27
Patients with Serumphosphor greater than 7 mg/dL	13

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	29
Patient months included in arterial venous fistula and catheter summaries	212
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	44
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	17

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary	28
Hospitalization Rate in facility	236.9 (As Expected)
Hospitalization Rate: Upper Confidence Limit	427.8
Hospitalization Rate: Lower Confidence Limit	137.4

The rate of readmission show you whether patients who were being treated regularly at Vamana, Inc were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) Year	January, 2016 - December, 2016
Readmission Rate in facility	18.2 (As Expected)
Readmission Rate: Upper Confidence Limit	31.4
Readmission Rate: Lower Confidence Limit	8.8